Product Images Metoprolol Succinate

The text describes the results of a study called MERIT-HF, which looked at the effectiveness of Wetoprolol Succinate extended-release tablets for reducing total mortality or hospitalization for heart failure. The study results are broken down by subgroups, such as ethnicity and prior medical history. The text includes information on the mean ejection fraction and heart rate for these subgroups, as well as relative risks and confidence intervals.*

Each tablet contains 2375 mg metoprolol succinate equivalent to 25 mg metoprolol tartrate, USP. Dosage and use: See package insert. Store at 25°C (77°F); excursions permitted 10-15°C/30°C (59-86°F). (see USP Controlled Room Temperature) Protect from moisture. WARNING: As with all medications, keep out of the reach of children. Manufactured for TWi Pharmaceuticals USA, Inc. Paramus, NJ 07652. Manufactured by Visum Pharmaceutical Co, Ltd. Metoprolol Succinate = Extended-Release Tablets. Rx only 100 Tablets.*

This is a medication containing 475mg of metoprolol succinate equivalent to 50mg of metoprolol tartrate in each tablet. The package insert should be consulted for dosage and usage instructions. The tablets should be stored at 25°C with excursions between 15°C-30°C permitted. The medication is manufactured by Visum Pharmaceutical Co, Ltd, and distributed by TWI Pharmaceuticals USA, Inc. This medication should be kept out of the reach of children.*

This is a description of medication containing 95mg of metoprolol succinate, which is equivalent to 100mg of metoprolol tartrate. The dosage and method of use are provided in the package insert. The medication should be stored at 25°C (77°F), with temporary excursions allowed at 15°C-30°C (59°F-86°F). The use of medication should be kept out of reach of children due to its sensitive nature. The medicine labeled as Metoprolol Succinate is prepared, packaged, and distributed by TWi Pharmaceuticals USA, Inc. 100 Tablets are included in the package, with a manufacturing date of 06/2020.*

Metoprolol Succinate Extended-Release tablets contain 190mg of metoprolol succinate and 200mg of metoprolol tartrate for medical use. Dosage and usage instructions can be found in the package insert. The tablets must be stored at a temperature between 15°C to 30°C and should be kept away from moisture. The drug should be kept out of reach of children. These tablets are manufactured by Visum Pharmaceutical Co., Ltd. for TWi Pharmaceuticals USA, Inc. and are available in a bottle containing 100 tablets. The product's NDC number is 24979-040-01, and it is a prescription-only medication.*